DE68903165T2 - Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein. - Google Patents

Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.

Info

Publication number
DE68903165T2
DE68903165T2 DE8989313362T DE68903165T DE68903165T2 DE 68903165 T2 DE68903165 T2 DE 68903165T2 DE 8989313362 T DE8989313362 T DE 8989313362T DE 68903165 T DE68903165 T DE 68903165T DE 68903165 T2 DE68903165 T2 DE 68903165T2
Authority
DE
Germany
Prior art keywords
hepatitis
infection
cdna
nanb
hepatitis virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989313362T
Other languages
German (de)
English (en)
Other versions
DE68903165D1 (de
Inventor
Shunji Mishiro
Tetsuo Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuno Japan Inc
Original Assignee
Immuno Japan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Japan Inc filed Critical Immuno Japan Inc
Application granted granted Critical
Publication of DE68903165D1 publication Critical patent/DE68903165D1/de
Publication of DE68903165T2 publication Critical patent/DE68903165T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C07K16/118—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8989313362T 1988-12-21 1989-12-20 Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein. Expired - Fee Related DE68903165T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63322547A JPH02167081A (ja) 1988-12-21 1988-12-21 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質

Publications (2)

Publication Number Publication Date
DE68903165D1 DE68903165D1 (de) 1992-11-12
DE68903165T2 true DE68903165T2 (de) 1993-03-11

Family

ID=18144889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989313362T Expired - Fee Related DE68903165T2 (de) 1988-12-21 1989-12-20 Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.

Country Status (10)

Country Link
US (1) US5077193A (enExample)
EP (1) EP0377303B1 (enExample)
JP (1) JPH02167081A (enExample)
AT (1) ATE81357T1 (enExample)
CA (1) CA2005950C (enExample)
DE (1) DE68903165T2 (enExample)
DK (1) DK648689A (enExample)
ES (1) ES2045475T3 (enExample)
GR (1) GR3006171T3 (enExample)
IE (1) IE63306B1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5824649A (en) * 1988-06-17 1998-10-20 Genelabs Technologies, Inc. DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
US5789559A (en) * 1988-06-17 1998-08-04 Genelabs Technologies, Inc. DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
NO905438L (no) 1989-12-18 1991-06-19 Wellcome Found Virusmiddel.
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
US5747339A (en) 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US7863008B2 (en) 1990-08-25 2011-01-04 Bioprocess Pty Ltd. Method for detecting NANBV associated seroconversion
CA2090335A1 (en) * 1990-08-25 1992-02-26 Suzanne Zebedee Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2065690A1 (en) * 1991-04-10 1992-10-11 Hiroaki Okamoto Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
JPH06511149A (ja) * 1991-09-13 1994-12-15 カイロン　コーポレイション 免疫反応性ｃ型肝炎ウイルスのポリペプチド組成物
WO1994018217A1 (en) * 1993-02-03 1994-08-18 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
US5859230A (en) * 1992-07-30 1999-01-12 Genelabs Technologies, Inc. Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
SG46456A1 (en) * 1992-11-27 1998-02-20 Innogenetics Nv Process for typing of hcv isolates
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US5874563A (en) * 1994-05-20 1999-02-23 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
ES2596753T3 (es) * 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
NZ227011A (en) * 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
IL91371A0 (en) * 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood

Also Published As

Publication number Publication date
IE63306B1 (en) 1995-04-05
DK648689A (da) 1990-06-22
DK648689D0 (da) 1989-12-19
ES2045475T3 (es) 1994-01-16
EP0377303B1 (en) 1992-10-07
EP0377303A1 (en) 1990-07-11
CA2005950A1 (en) 1990-06-21
GR3006171T3 (enExample) 1993-06-21
ATE81357T1 (de) 1992-10-15
DE68903165D1 (de) 1992-11-12
CA2005950C (en) 1996-06-11
JPH02167081A (ja) 1990-06-27
US5077193A (en) 1991-12-31
IE894083L (en) 1990-06-21

Similar Documents

Publication Publication Date Title
DE68903165T2 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
DE68928119T2 (de) Non-A, non-B-Hepatitisvirus-Antigenpeptid
AT400724B (de) Virales polypeptid
DE69533675T2 (de) Monoklonaler antikörper gegen rhesus d (d7c2)
DE68929467T2 (de) HIV-2 Varianten
EP0770679B1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
DE3886363T3 (de) NANBV-Diagnostika
DE69637264T2 (de) Virales Material und Multiple-Sklerose assoziierte Nukleotidfragmente mit diagnostischen, prophylaktischen und therapeutischen Verwendungen
DE69434117T3 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
DE69132332T2 (de) Hepatitis c-virus-epitope
DE60013287T2 (de) Früherkennung der flaviviren unter verwendung des ns1-glycoproteins
DE3588177T2 (de) Verfahren zur Feststellung der Anwesenheit eines selbstimmunen Antikörpers
DE69532062T2 (de) Immuntests von nicht-A, nicht-B Hepatitisvirus-verwandten Antigenen, monoklonale Antikörper und diese synthetisierende Hybridome
DE69433964T2 (de) Multiple Sclerosis Virus
DE69836758T2 (de) Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv
DE68926658T2 (de) Diagnostische gene zum nachweis von toxoplasmose
EP0124896B1 (de) Verfahren zur Gewinnung von Viren bzw. Virusantigenen und deren Anwendung in Diagnose und Therapie (Impfstoff)
DE69224134T2 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
US5176994A (en) Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein
DE69106141T2 (de) Non-a non-b sequenzen.
EP0564532B1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
DE69829587T2 (de) Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren
DE69731106T2 (de) Neue pikcornaviren, impfstoffe und diagnostische kits
DE69121933T2 (de) Nukleinsäuren, Antigene und Antikörper betreffend Non-A, Non-B Hepatitis und deren Nachweisreagenzien
DE60034243T2 (de) Rekombinante bifunktionale fusionsproteine zur abtreibung variabler viren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee